SEC Form 4 · accession 0001104659-19-013734
Elanco Animal Health Inc · ELAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
LILLY ELI & CO
10% Owner
Period of report
Mar 11, 2019
Accepted (ET)
Mar 11, 2019 · 8:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 11, 2019 | D | 293,290,000 | — | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Eli Lilly and Company ("Lilly") disposed of 293,290,000 shares of common stock of the Issuer in exchange for 65,000,775 shares of Lilly common stock pursuant to a registered exchange offer to Lilly's common shareholders. The final exchange ratio was 4.5121 shares of Issuer common stock per share of Lilly common stock accepted in the exchange offer.